Incyte Corp (INCY)

NASDAQ · Biotechnology

125.01
+1.79 (+1.45%)
Updated Sep 1, 8:13 PM ET
AI Rating
Buy
Overall Score
75
Trend
100
Momentum
44
Risk
79

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 19, 2025 260 sessions Aug 31, 2026

AI Analysis

Incyte Corp is trading at $125.01, up 1.45% on the session. The 50 day average sits at $119.12 and the 200 day at $104.29, which puts the stock in a uptrend. RSI is at 50.8, which reads as neutral, and MACD is bearish crossover. Volume is above average.

The nearest support is around $117.56 with resistance near $124.57, so that band frames the current range. Average daily movement is roughly $3.44, or about 2.8% of the share price, which is what any stop placement has to allow for. The overall health score of 75 out of 100 combines a trend score of 100, momentum of 44 and a risk score of 79.

Technical indicators

RSI (14)
50.8
neutral
MACD
2.312
bearish crossover
SMA 20
123.75
SMA 50
119.12
SMA 200
104.29
uptrend
ATR (14)
3.44
avg daily range
Support
117.56
Resistance
124.57
Volume vs 20d
1.12x
above average
Volatility
24.3%
annualised
1 month
+3.10%
3 months
+28.91%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.